Neurodevelopmental Therapy for Spastic Cerebral Palsy (NDT)
Cerebral Palsy, Spastic, Diplegia, Spastic
About this trial
This is an interventional treatment trial for Cerebral Palsy focused on measuring Neurodevelopmental therapy, NDT, Spastic cerebral palsy, Physical Therapy, Rehabilitation, Neurorehabilitation
Eligibility Criteria
Inclusion Criteria:
• A diagnosed Spastic Cerebral Palsy (patient's diagnosis of CP confirmed by an expert pediatrician neurologist)
- Spastic CP
- No other severe abnormalities such as seizure
- Aged 2-6 years
- Both Genders
Exclusion Criteria:
- Medical procedures likely to affect motor function such as botulinum toxin injections
- Orthopedic remedial surgery
- Mental retardation, or a learning disability.
Sites / Locations
- The University of Lahore Teaching Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Neurodevelopmental Therapy
Routine Physical Therapy
The treatment group received neurodevelopment treatment lasting for 3 months (3sessions per week). Additionally, for this study, the NDT programme included passive stretching of the lower limb muscles (e.g. hamstrings, gastrocsoleus), followed by techniques of reducing spasticity and facilitating more normal patterns of movement while working on motor functions. In each session, exercises included patients sustaining themselves on their forearms and hands, sitting, crawling, semi-kneeling, and in standing positions supported by the Physical therapist until tone reduction achieved. Balance and corrective reactions were developed by using a CP ball and tilt board.
The control group underwent the exercises (stretching, passive range of motion, and active range of motion).